<DOC>
	<DOCNO>NCT00509418</DOCNO>
	<brief_summary>The purpose study evaluate whether Viusid , nutritional supplement , combination diet exercise improve histological result ( steatosis , necro-inflammatory activity fibrosis ) comparison diet exercise , 24 week treatment .</brief_summary>
	<brief_title>Efficacy Safety Viusid Patients With Nonalcoholic Steatohepatitis</brief_title>
	<detailed_description />
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<criteria>Histological diagnosis steatohepatitis ( minimal histological criterion steatohepatitis include steatosis involve least 5 % hepatocytes , lobular inflammation , and/or fibrosis ) Age 18 70 year Ability provide inform consent Absence significant alcohol ingestion ( weekly ethanol consumption le 40 g ) Presence form liver disease ( viral autoimmune hepatitis , druginduced liver disease , metabolic hereditary liver disease Î±1 antitrypsin deficiency ) Pregnancy lactation Decompensated cirrhosis Presence secondary cause NAFL medication induce steatosis ( corticosteroid , estrogen , methotrexate , amiodarone , tamoxifen calcium channel blocker ) gastrointestinal bypass surgery Pharmacological treatment potential benefit NAFL include ursodeoxycholic acid , vitamin E , betaine , pioglitazone , rosiglitazone , metformin , pentoxifylline gemfibrozil Fasting glucose level great 250 mg per deciliter ( 13.3 mmol per liter ) Contraindication liver biopsy Refusal participate study Concomitant disease reduce life expectancy Severe psychiatric condition Drug dependence</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>Nonalcoholic steatohepatitis</keyword>
	<keyword>Nonalcoholic Fatty Liver</keyword>
	<keyword>Nutritional supplement</keyword>
	<keyword>Diet</keyword>
	<keyword>Exercise</keyword>
</DOC>